SINT (SINTX Technologies) ROCE %: -238.76% (As of Mar. 2026)

What is SINTX Technologies ROCE %?

SINTX Technologies SINT +3.78% 27 ROCE % is -238.76% as of Mar. 2026. GuruFocus rates SINT with a GF Score™ of 27/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SINTX Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was -238.76%.

SINTX Technologies (NAS:SINT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SINTX Technologies ROCE % Related Terms

SINTX Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for SINTX Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SINTX Technologies ROCE % Chart

SINTX Technologies Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-39.79

-89.76

-81.94

-110.56

-156.20

SINTX Technologies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-109.38	-113.25	-200.71	-137.80	-238.76

27GF Score

SINTX Technologies Inc SINT

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

SINTX Technologies ROCE % Calculation

SINTX Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-10.312	/	( ( (9.413 - 1.982)	+	(9.506 - 3.733) )	/ 2 )
	=	-10.312	/	( (7.431	+	5.773)	/ 2 )
	=	-10.312	/	6.602
	=	-156.20 %

SINTX Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-11.236	/	( ( (9.506 - 3.733)	+	(7.811 - 4.172) )	/ 2 )
	=	-11.236	/	( ( 5.773	+	3.639 )	/ 2 )
	=	-11.236	/	4.706
	=	-238.76 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -238.76% mean?

SINTX Technologies (SINT) has a ROCE % of -238.76% as of Mar. 2026.

Is SINTX Technologies' ROCE % too high?

SINTX Technologies' current ROCE % is -238.76%. Overall, SINTX Technologies has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does SINTX Technologies' ROCE % compare to VVOS and AIDX?

SINTX Technologies' ROCE % of -238.76% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SINTX Technologies's current ROCE % is -238.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is SINTX Technologies stock overvalued right now?

Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.93 — trading 1186.7% above its estimated fair value. The current ROCE % is -238.76%. SINTX Technologies' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For SINTX Technologies (SINT), the current ROCE % is -238.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SINTX Technologies (SINT) Overvalued in 2026?

Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued. The current stock price of $1.93 is trading 1186.7% above its estimated GF Value™ of $0.15. GuruFocus considers SINTX Technologies to be Significantly Overvalued.

Key valuation signals for SINT:

ROCE %: -238.76%
GF Value™: $0.15 vs. price of $1.93 (1186.7% above fair value)
GF Score™: 27/100 with 7 warning signs

No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SINTX Technologies Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies VVOS AIDX ALUR POAS USAQ TNON ALRTF NVNO BMRA STME ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges 0A8S:UK

Address 1885 West 2100 South, Salt Lake City, UT, USA, 84119

Website https://www.sintx.com

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

27GF Score

Get the complete analysis for SINT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.93

Price

$0.15

GF Value

View SINT Analysis

See ROCE % data for all stocks →